Skip to content
ClinCalc Pro
Menu
Urinary alkaliniser

Potassium citrate with potassium bicarbonate

This oral combination of potassium citrate with potassium bicarbonate is used as an alkalinising potassium preparation, for instance to relieve discomfort of mild urinary infection or to alkalinise the urine, rather than purely for potassium replacement.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Citrate and bicarbonate are metabolised or excreted to raise urinary pH, while both salts supply potassium; alkalinisation can ease dysuria and discourages the formation of certain urinary crystals.

Prescribing in practice

  • Avoid or use with great caution in renal impairment and alongside potassium-sparing diuretics or RAS inhibitors, since the potassium load can cause serious hyperkalaemia.
  • It is not appropriate where the urine is already alkaline or in conditions worsened by an alkali load.
  • Dilute the preparation well with water and take after food to reduce gastric irritation.

Monitoring

Monitor serum potassium and renal function, particularly with repeated use or in at-risk patients.

Counselling the patient

  • Dilute the dose well with water and take it after meals.
  • Seek review if urinary symptoms persist beyond a couple of days.
  • Report muscle weakness or an irregular heartbeat.

Evidence & guidelines

Long-standing symptomatic use for cystitis and urinary alkalinisation is reflected in current prescribing references and the SPC, which stress caution over the potassium content.

Reference: BAUS guidelines; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.